Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide or fluticasone added to tiotropium and salmeterol in COPD
2007-003169-42Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ciclesonide and fluticasone propionate in chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Trough forced expiratory volume in one second response. Started Aug 2007; status: completed.
02
Drugs
ciclesonidefluticasone propionate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2007-003169-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003169-42.